Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA/NIH INFORMED CONSENT REGS TO BE RECONCILED AT CONSENSUS WORKSHOP; EMERGENCY RESEARCH GUIDE NEEDS REVISION IN LIGHT OF TREATMENT ADVANCES -- FDAer

Executive Summary

FDA and the National Institutes of Health will try to reconcile their informed consent regulations at a workshop expected to be held sometime this fall for patients, physicians, ethicists and members of Institutional Review Boards, FDA Deputy Commissioner Mary Pendergast told a May 23 hearing of Rep. Wyden's (D-Ore.) House Small Business/Regulation Subcommittee.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS024539

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel